SARS-CoV-2 another kind of liver aggressor, how does it do that?
Sonia A. Lozano-Sepúlveda, Kame A. Galán-Huerta, Natalia Martínez-Acuña, Daniel Arellanos-Soto, Ana María Rivas-Estilla
Abstract
Clinical manifestations of SARS-CoV-2 infection include more frequently fever and cough, but complications (such as pneumonia, respiratory distress syndrome, and multiorgan failure) can occur in persons with additional comorbidities. Liver dysfunction is one of the most striking affections among patients suggesting that SARS-CoV-2 may represent a new king of liver aggressor. However, the molecular process underlying this phenomenon is still unclear. In this work, we overview the most recent findings between the molecular biology of the virus, pathogenic mechanisms, and its relationship to liver disease observed in patients.